[b]NSAV Historical February Running chart[/b]
[IMG]http://i1263.photobucket.com/albums/ii625/subflyer8/NSAVConversion_zpsc562187a.png [/IMG]
[url]http://i1263.photobucket.com/albums/ii625/subflyer8/NSAVConversion_zpsc562187a.png[/url] Chart Direct Link
[b]NSAV INFO![/b]
Share Structure:
Market Value1 $248,720 a/o Jan 25, 2013
Shares Outstanding 621,801,136 a/o Jan 23, 2013
Float 500,721,621 a/o Jan 23, 2013
Authorized Shares 1,000,000,000 a/o Jan 23, 2013
Par Value 0.001
[url]http://www.otcmarkets.com/stock/NSAV/company-info[/url] OTC markets Direct Link
[b]4 Day Historical Volume![/b]
Jan 22, 2012 Volume: 4,710,940
Jan 23, 2012 Volume: 13,864,667
Jan 24, 2012 Volume: 58,861,564 (VERT was taken out Jan 24, 2012)
Jan 25, 2012 Volume: 61,966,220 (VNDM was taken out Jan 25, 2012)
[b]Volume is increasing! Conversions are now at an end!![/b]
[b]Hystorical September 26, 2012 E-mail Correspondence between CEO
of NSAV David Saltrelli and another Investor![/b]
[quote]CEO ANSWERS E-MAIL:
Question: What are the goals for this company moving forward? I don't see any definitive goals set for the company on the website, reaching millions of buyers is not exactly an affirmative answer for stock holders when looking to invest in the stock.
ANSWER: NSAV sells Savings Certificates. Our goal is to sell millions of them.
Go to our website and click on the 4 sections and follow the links and you will see how we make the respective sales.
We expect to be profitable in October and then we expect to double profits every month for the next 6 - 10 months. The 6 month profit goal is $1,000,000 per month from selling Savings Certificates.
Question: was just concerned I have not heard or seen any follow ups. Is FamilyCoOp going to run ads? Also, who is selling the sales certificates if you don't mind me asking? And by profitable in October do you mean the 3rd quarter results that are due out will reveal a strong quarter?
ANSWER NSL sells through Affiliate Partners and also direct.
Family Savings CoOp advertises their program
Our quarter ended 8/31/12 and the Q should be out around 10/15/12
October is in this current quarter which will end November 30th.
Question: what is going on with the stock, Can you help the stock by saying something?
Answer: Nothing we can do at the current time. Asher and Southridge are converting their loans into stock and selling the stock in the market.
Nothing I can say to help at this time.
We are selling everyday and we anticipate being profitable in October. That is what we are concentrating all our efforts on.
Question: Does Asher and Southridge converting their loans into stock and selling the stock in the market help the stock down the road I would hope?
Answer:
By converting loans into stock it pays off the loans and the company becomes debt free. Then with profits and no debt the stock should go up, but nothing is guaranteed. All the best,
David Saltrelli, President
Net Savings Link, Inc. | Stock Symbol: NSAV
(727) 442 2600 (Office) | (727) 482 5800 (Cell)
www.NetSavingsLink.com | LinkedIn
Fundraising | Incentives | Joint Ventures | Business Opportunities [/quote]
[b][u]E-Mail Correspondence between CEO of NSAV David Saltrellli and myself![/u][/b]
[quote]On Jan 25, 2013, at 3:38 PM, David Saltrelli <david@netsavingslink.com> wrote:
Alex,
>
> Our 10K, year end report, is due February 28th. All info on conversions and sales will be in there as well are information on what has occurred during the last 60 days. Sorry, but you will have to wait for that report. We may put out news sooner via a press release. We cannot give information out to individual shareholders.
>
>
> All the best,
>
>
>
> David Saltrelli, President
>
> Net Savings Link, Inc. | Stock Symbol: NSAV
>
> (727) 442 2600 (Office) | (727) 482 5800 (Cell)
>
> www.NetSavingsLink.com | LinkedIn
>
> Fundraising | Incentives | Joint Ventures | Business Opportunities
>
>
>
> On Fri, Jan 25, 2013 at 3:07 PM, Alex Woods- Leo <alexmwoodsleo@gmail.com> wrote:
>
> David
>
> My name is Alex Leo and i am a current shareholder and was wondering how many conversions are left. Seems theres still some shares to be sold. We took out VERT yesterday and we are stuck on VNDM right now. However many of us are wondering about how many more shares are to be dumped?
>
> If this can be answered this would be great. Also in an e-mail to a fellow investor back in September you had stated that NSAV should be putting out financials around Feb 28. is that still the case? If so does it still look like NSAV may be posting Debt Free status?
>
> Long and Strong
>
> Alex Leo
[/quote]
NSAV Historical February Running chart
Top 10 Most Recent News Articles
Island Pacific Opens 22nd Store in Eagle Rock, L.A.
Winning the Grocery Game One Store at a Time Here's the scoop—Island Pacific Seafood Market just rolled up the shutters on their 22nd supermarket at 4044 N. Eagle Rock Boulevard in the bustling hub of Glassell Park, Los Angeles. This ain't just some ho-hum store opening; it's a celebration rooted in Filipino heritage, smack in the middle of Northeast L.A., where culture...
Continue Reading
Singapore Welcomes IASO Bio's Pioneering BCMA CAR-T Therapy
IASO Bio’s done it—they've taken a leap into Singapore with their fully human BCMA-targeted CAR-T cell therapy, FUCASO. November 3 was the official launch day, a big moment in Southeast Asia’s healthcare hub. And we're not just talking any therapy. This is a world-first fully human BCMA CAR-T hitting Singapore's market after getting the nod from the Health Sciences...
Continue Reading
KFC Teams with Marvel for Record-Breaking Menu Launch
Movie Magic on the Menu When was the last time a bucket of fried chicken sent such ripple effects through pop culture? KFC's decision to sling Doctor Doom-inspired dishes across 100 countries smells like genius business mixed with a dash of the absurd. Just imagine: an empire of battered birds aligning with Marvel's latest cinematic heavy hitter, "Avengers: Doomsday." Now...
Continue Reading
Taiwan's Bold Bid: From Tech Hub to Capital Magnet
Ambitious Plans Unveiled at Taiwan Weeks 2026 Forget the usual humdrum; Taiwan’s pulling no punches in its bid to become a capital powerhouse in Asia. If you'd told me years ago that Taiwan was eyeing dominance in asset management, I might've laughed. But at the 2026 Taiwan Weeks, they showed they're dead serious about it. Over 400 bigwigs and market shakers gathered,...
Continue Reading
LIME Faces Investigation Amid Earnings Shortfall
Financial Miss Spurs Investigation When you've been in this racket as long as I have, you learn that missing consensus earnings even by a few cents can stir up a financial hornet's nest. That's precisely where Neutron Holdings Inc., better known as Lime, finds itself. With their third-quarter earnings slipping two cents below expectation, at $0.63 against a $0.66 to $0.68...
Continue Reading
SensAI Veritas Unveils New Risk Intelligence Tools
Transforming Security Assessments with SensAI Security screenings are about to get a serious upgrade with SensAI Veritas rolling out their latest toys—the SensAI Gateway™ and Helm™. Forget what you knew about traditional identity checks; this is all about diving deeper to sniff out those hidden risks before anyone gets a green light. From Static Checks to Dynamic...
Continue Reading
Saga Metals Advances Radar Project with HQ Drill Success
Digging Deep at Trapper North: Saga's Strategic Drill Move There's nothing like the thrill of discovery, especially in the rough-and-tumble world of mining exploration. Saga Metals Corp., anchored deep in the critical minerals scene, has wrapped up an HQ-diameter drill program at its Radar Project, smack dab near Cartwright, Labrador. You hear 1,010 meters and maybe...
Continue Reading
GaNrich: Gallium Nitride Game-Changer Expands Global Reach
Rattling the Silicon Cage: GaNrich's Transformative Climb Well, folks, here's a story that makes even the most stoic traders sit up and take notice: GaNrich Semiconductor, a Taiwan-based trailblazer, is serving a wallop to the traditional silicon power device monopoly. By expanding their GaN power device portfolio to cover voltages ranging a whopping 40V to 1200V, GaNrich...
Continue Reading
Ecobat Workers Secure Landmark Three-Year Contract
A Breakthrough for Ecobat Workers Man, when it comes to contracts, this recent deal at Ecobat is as game-changing as they get. A vote just ripped through like a hurricane, with 220 workers under Teamsters Local 986 eagerly ratifying a new three-year agreement that signals more than just a better payday. We're talking the largest wage boost these folks have clapped eyes on...
Continue Reading
Flexcompute's Physics Twin Revolutionizes Space Docking
There's a new player shaking up the space game, and it's called the Physics Twin. Flexcompute, a trailblazer in AI-driven physics modeling, just rolled this out to help figure out how thruster plumes mess with nearby spacecraft. Trust me, this ain't your garden-variety simulation tool. Why Thruster Plumes Matter If you're in the business of dancing spacecraft around each...
Continue ReadingTop 5 Most Recently Viewed Articles
Citi Confirms Positive Outlook for Alnylam Pharmaceuticals' Growth
Citi Confirms Positive Outlook for Alnylam Pharmaceuticals Citi has reaffirmed its Buy rating and a price target of $342.00 for Alnylam Pharmaceuticals (NASDAQ: ALNY). This supportive action follows Alnylam's recent TTR Investor Day presentation, which underscored the challenges and treatment needs related to transthyretin amyloid cardiomyopathy (ATTR-CM). The event...
Continue Reading
Orchid Island Capital's Monthly Dividend Announcement Update
Updates on Orchid Island Capital's Monthly Dividend Orchid Island Capital, Inc. (NYSE: ORC) has officially declared a monthly cash dividend of $0.12 per share for May 2025, providing a continued commitment to shareholder returns. This dividend is slated for distribution to stockholders on June 27, 2025, ensuring that investors remain rewarded for their confidence in the...
Continue Reading
Rigel Pharmaceuticals: What to Expect from Upcoming Earnings
Preparing for Rigel Pharmaceuticals' Quarterly Earnings Rigel Pharmaceuticals (NASDAQ:RIGL) is set to unveil its quarterly earnings soon. Investors may benefit from understanding key elements ahead of this important announcement. Expected Earnings Insights Analysts predict that Rigel Pharmaceuticals will report an earnings per share (EPS) of $0.85. This forecast reflects...
Continue Reading
Biodesix Announces Upcoming Presentation at Growth Conference
Biodesix, Inc. Presentation at Major Growth Event Biodesix, Inc. (NASDAQ: BDSX), a pioneer in diagnostic solutions, is gearing up to present at the Canaccord Genuity 45th Annual Growth Conference. The event will showcase insights into the company's innovative approaches to enhancing clinical care and patient outcomes. Key Details of the Conference Engagement Scheduled for...
Continue Reading
Transforming Office Towers: Three Collective's Apartment Vision
Three Collective Unveils Adaptive Apartment Community Welcome to the future of urban living! Three Collective, often referred to as 3co, represents a remarkable transformation of underutilized office towers into a modern and vibrant apartment community featuring 675 apartments and a wealth of amenities. Reimagining Office Spaces into Homes Driven by The Wolff Company's...
Continue Reading